NYSE:HHS

Harte Hanks (HHS) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$6.92
$7.04
50-Day Range
$2.69
$2.94
52-Week Range
$1.10
$3.96
Volume
4,891 shs
Average Volume
14,350 shs
Market Capitalization
$50.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
HHS stock logo

About Harte Hanks Stock (NYSE:HHS)

Harte-Hanks, Inc. engages in the provision of marketing solutions. It specializes in consulting, data analytics, creative services, digital and social media, marketing strategy, marketing technology, and other related services. It supports a range of customers in the field of technology, travel and leisure, entertainment, pharmaceuticals, automotive, finance, and retail. The company was founded in 1923 and is headquartered in San Antonio, TX.

HHS Stock News Headlines

Thousands of investors use this no cost solution | Do you?
In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.
Q4 2023 Harte Hanks Inc Earnings Call
Thousands of investors use this no cost solution | Do you?
In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.
3 Small-Cap Stocks With Mega-Cap Potential for 10X Gains
Harte Hanks Strengthens Senior Leadership Team
144K Reasons To Be Bullish On Harte-Hanks Stock
Bradley Radoff Bought 9.4% More Shares In Harte Hanks
Harte-Hanks Inc HHS
Harte Hanks Reports Fiscal 2023 Third Quarter Results
See More Headlines
Receive HHS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Harte Hanks and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/14/2024
Today
4/23/2024
Next Earnings (Estimated)
5/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Direct mail advertising services
Sub-Industry
Advertising
CUSIP
41619610
Employees
1,962
Year Founded
N/A

Profitability

Net Income
$-1,570,000.00
Pretax Margin
-1.00%

Debt

Sales & Book Value

Annual Sales
$191.49 million
Cash Flow
$1.00 per share
Book Value
$2.75 per share

Miscellaneous

Free Float
6,352,000
Market Cap
$51.04 million
Optionable
Not Optionable
Beta
0.64
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

HHS Stock Analysis - Frequently Asked Questions

When is Harte Hanks' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our HHS earnings forecast
.

How were Harte Hanks' earnings last quarter?

Harte Hanks, Inc. (NYSE:HHS) posted its quarterly earnings results on Thursday, March, 14th. The business services provider reported $0.35 EPS for the quarter. The business services provider earned $49.49 million during the quarter, compared to analyst estimates of $47 million. Harte Hanks had a negative net margin of 0.82% and a positive trailing twelve-month return on equity of 14.27%.

What other stocks do shareholders of Harte Hanks own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Harte Hanks investors own include Amyris (AMRS), Eldorado Resorts (ERI), Nokia Oyj (NOK), NVIDIA (NVDA), Block (SQ), Inovio Pharmaceuticals (INO), Prospect Capital (PSEC), Ambarella (AMBA), Delta Air Lines (DAL) and Telefonaktiebolaget LM Ericsson (publ) (ERIC).

This page (NYSE:HHS) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners